Active — Not RecruitingNot Applicable

Effect of a Health Pathway for People With Persistent Symptoms Covid-19

France400 participantsStarted 2023-11-15

Plain-language summary

People with persistent symptoms of covid-19 have increased needs for needs for management of their overall health (physical, psychological and social). Persistent covid-19 symptoms have a negative impact on quality of life. By proposing a follow-up and an intervention on the reduction of these symptoms, the symptoms, the study will improve quality of life.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria * Persons who have been infected with Covid-19. * Person with persistent clinical signs of Covid-19 for more than 12 weeks, referred by one of the partner structures of the project. The persistent signs of Covid-19 are: fatigue which can be severe, neurological disorders neurological disorders (cognitive, sensory, headaches), cardio-thoracic disorders (pain and chest tightness, tachycardia, dyspnea, cough) and disorders of smell and taste. Pain, digestive disorders and skin disorders are also common. * Person who has agreed to participate and has given informed consent to participate in the study Exclusion Criteria: * Refused to participate in the study * Person under legal protection * Person with severe cognitive impairment

What they're measuring

the evolution of the quality of life

Timeframe: at the end of the 6-month follow-up

Trial details

NCT IDNCT05787366

SponsorCentre Hospitalier Universitaire de Saint Etienne

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-09-12

View on ClinicalTrials.gov More COVID-19 trials